The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis.

Abstract

Obesity and its associated complications have reached epidemic proportions in the USA and also worldwide, highlighting the need for new and more effective treatments. Although the neuropeptide oxytocin (OXT) is well recognised for its peripheral effects on reproductive behaviour, the release of OXT from somatodendrites and axonal terminals within the central nervous system (CNS) is also implicated in the control of energy balance. In this review, we summarise historical data highlighting the effects of exogenous OXT as a short-term regulator of food intake in a context-specific manner and the receptor populations that may mediate these effects. We also describe what is known about the physiological role of endogenous OXT in the control of energy balance and whether serum and brain levels of OXT relate to obesity on a consistent basis across animal models and humans with obesity. We describe recent data on the effectiveness of chronic CNS administration of OXT to decrease food intake and weight gain or to elicit weight loss in diet-induced obese (DIO) and genetically obese mice and rats. Of clinical importance is the finding that chronic central and peripheral OXT treatments both evoke weight loss in obese animal models with impaired leptin signalling at doses that are not associated with visceral illness, tachyphylaxis or adverse cardiovascular effects. Moreover, these results have been largely recapitulated following chronic s.c. or intranasal treatment in DIO non-human primates (rhesus monkeys) and obese humans, respectively. We also identify plausible mechanisms that contribute to the effects of OXT on body weight and glucose homeostasis in rodents, non-human primates and humans. We conclude by describing the ongoing challenges that remain before OXT-based therapeutics can be used as a long-term strategy to treat obesity in humans.

• Authors: Elizabeth A Lawson, Pawel K Olszewski, Aron Weller, James E Blevins
• Journal: Journal of neuroendocrinology (J Neuroendocrinol) Vol. 32 Issue 4 Pg. e12805 (04 2020) ISSN: 1365-2826 [Electronic] United States
• PMID: 31657509 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review)
• Copyright: © 2019 British Society for Neuroendocrinology.

Chemical References

• Blood Glucose
• Oxytocin

Topics

• Animals
• Appetitive Behavior (drug effects, physiology)
• Blood Glucose (metabolism)
• Body Weight (drug effects, physiology)
• Homeostasis (drug effects, physiology)
• Humans
• Oxytocin (metabolism, pharmacology)